• Je něco špatně v tomto záznamu ?

Does ibuprofen affect the expression of alginate genes in pathogenic Pseudomonas aeruginosa strains

N. Babaei, B. Rasti, H. Zamani

. 2022 ; 67 (4) : 617-623. [pub] 20220324

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22020224

Conversion to mucoid form is a crucial step in the pathogenesis of P. aeruginosa in burns and cystic fibrosis (CF) patients. Alginate is considered the major component of biofilm and is highly associated with the formation of mucoid biofilm in this species. Nonsteroid anti-inflammatory drugs (NSAIDs), including ibuprofen, have shown promising antibacterial and antibiofilm potential for bacterial pathogens. In this study, we aimed to evaluate the effect of ibuprofen on the expression of alginate synthetase (alg8), GDP-mannose dehydrogenase (algD), and alginate lyase (algL) genes in multiple drug-resistant (MDR) P. aeruginosa strains. The biofilm formation potential and the expression of alg8, algD, and algL among the bacteria treated with ibuprofen (at sub-inhibitory concentration) were investigated using the crystal violet staining and real-time PCR assays, respectively. The minimum inhibitory concentration of ibuprofen for the studied strains was determined 1024-2048 μg/mL. We observed that ibuprofen was able to reduce bacterial biofilm by 51-77%. Also, the expression of alg8, algD, and algL decreased by 32, 52, and 48%, respectively. The reduction of the genes responsible for alginate synthesis indicates promising antivirulece potential of ibuprofen to combat P. aeruginosa infection, especially in burns and CF patients. Our findings suggest that ibuprofen could be used to reduce the pathogenicity of P. aeruginosa that could be used in combination with antibiotics to treat drug-resistant infections.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22020224
003      
CZ-PrNML
005      
20240416152337.0
007      
ta
008      
220802s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-022-00962-9 $2 doi
035    __
$a (PubMed)35325409
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Babaei, Nastaran $u Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Guilan, Iran
245    10
$a Does ibuprofen affect the expression of alginate genes in pathogenic Pseudomonas aeruginosa strains / $c N. Babaei, B. Rasti, H. Zamani
520    9_
$a Conversion to mucoid form is a crucial step in the pathogenesis of P. aeruginosa in burns and cystic fibrosis (CF) patients. Alginate is considered the major component of biofilm and is highly associated with the formation of mucoid biofilm in this species. Nonsteroid anti-inflammatory drugs (NSAIDs), including ibuprofen, have shown promising antibacterial and antibiofilm potential for bacterial pathogens. In this study, we aimed to evaluate the effect of ibuprofen on the expression of alginate synthetase (alg8), GDP-mannose dehydrogenase (algD), and alginate lyase (algL) genes in multiple drug-resistant (MDR) P. aeruginosa strains. The biofilm formation potential and the expression of alg8, algD, and algL among the bacteria treated with ibuprofen (at sub-inhibitory concentration) were investigated using the crystal violet staining and real-time PCR assays, respectively. The minimum inhibitory concentration of ibuprofen for the studied strains was determined 1024-2048 μg/mL. We observed that ibuprofen was able to reduce bacterial biofilm by 51-77%. Also, the expression of alg8, algD, and algL decreased by 32, 52, and 48%, respectively. The reduction of the genes responsible for alginate synthesis indicates promising antivirulece potential of ibuprofen to combat P. aeruginosa infection, especially in burns and CF patients. Our findings suggest that ibuprofen could be used to reduce the pathogenicity of P. aeruginosa that could be used in combination with antibiotics to treat drug-resistant infections.
650    _2
$a algináty $7 D000464
650    _2
$a antibakteriální látky $x metabolismus $x farmakologie $7 D000900
650    _2
$a biofilmy $7 D018441
650    12
$a cystická fibróza $x mikrobiologie $7 D003550
650    _2
$a lidé $7 D006801
650    _2
$a ibuprofen $x metabolismus $x farmakologie $7 D007052
650    12
$a pseudomonádové infekce $x farmakoterapie $x mikrobiologie $7 D011552
650    _2
$a Pseudomonas aeruginosa $7 D011550
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rasti, Behnam $u Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Guilan, Iran
700    1_
$a Zamani, Hojjatolah $u Department of Biology, Faculty of Science, University of Guilan, Guilan, Iran. h_Zamani@guilan.ac.ir $1 https://orcid.org/0000000216224530
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 67, č. 4 (2022), s. 617-623
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35325409 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220802 $b ABA008
991    __
$a 20240416152334 $b ABA008
999    __
$a ok $b bmc $g 1845877 $s 1171470
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 67 $c 4 $d 617-623 $e 20220324 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20220802

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...